Geron
GERN
#6644
Rank
A$1.17 B
Marketcap
A$1.84
Share price
-3.73%
Change (1 day)
1.68%
Change (1 year)

Geron (GERN) - Total assets

Total assets on the balance sheet as of March 2026 : A$0.76 Billion

According to Geron's latest financial reports the company's total assets are A$0.76 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Geron - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-12-31A$0.85 B-10.77%
2024-12-31A$0.95 B65.04%
2023-12-31A$0.57 B106.54%
2022-12-31A$0.28 B-10.18%
2021-12-31A$0.31 B-11.45%
2020-12-31A$0.35 B48.93%
2019-12-31A$0.23 B-10.12%
2018-12-31A$0.26 B86.14%
2017-12-31A$0.14 B-21.8%
2016-12-31A$0.18 B-11.51%
2015-12-31A$0.20 B-3.13%
2014-12-31A$0.21 B179.2%
2013-12-31A$75.49 M-21.38%
2012-12-31A$96.03 M-38.47%
2011-12-31A$0.15 B-32.12%
2010-12-31A$0.22 B14.52%
2009-12-31A$0.20 B-19.61%
2008-12-31A$0.24 B-0.24%
2007-12-31A$0.25 B-10.61%
2006-12-31A$0.28 B1.84%
2005-12-31A$0.27 B61.39%
2004-12-31A$0.17 B7.24%
2003-12-31A$0.15 B47.57%
2002-12-31A$0.10 B-42.89%
2001-12-31A$0.18 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Gilead Sciences
GILD
A$80.10 B 10,436.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
A$10.44 B 1,274.06%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
A$0.15 B-78.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
A$3.63 B 377.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
A$15 M-98.03%๐Ÿ‡บ๐Ÿ‡ธ USA